(NASDAQ: FLGT) Fulgent Genetics's forecast annual revenue growth rate of 6.26% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.25%.
Fulgent Genetics's revenue in 2024 is $287,530,000.On average, 2 Wall Street analysts forecast FLGT's revenue for 2024 to be $8,371,169,947, with the lowest FLGT revenue forecast at $8,289,027,776, and the highest FLGT revenue forecast at $8,453,312,117. On average, 2 Wall Street analysts forecast FLGT's revenue for 2025 to be $9,795,416,434, with the lowest FLGT revenue forecast at $9,432,135,578, and the highest FLGT revenue forecast at $10,158,697,290.
In 2026, FLGT is forecast to generate $10,978,772,403 in revenue, with the lowest revenue forecast at $10,596,190,381 and the highest revenue forecast at $11,361,354,425.